256840.KQ
BNC Korea Co., Ltd.
KOE · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 2,620.00
−1.50%Year over year
Reported trailing growth
- Revenue
- -8.2%
- EBITDA
- -80.4%
- EBIT
- —
- EPS
- —
- Free cash flow
- -11.7%
- Operating cash flow
- -56.1%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +31.4%
- EBITDA
- -21.5%
- EBIT
- -60.0%
- Net income
- -66.8%
- EPS
- -65.8%
- Free cash flow
- -41.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026